NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Wed, 11 Jun · 11:56 IST

Neuland Laboratories Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has informed the stock exchanges that its management will participate in a Goldman Sachs India Non-deal Roadshow (NDR) on June 17, 2025, in Hyderabad. The meeting will be a group interaction with institutional investors and analysts. This is a routine investor engagement activity disclosed under SEBI Listing Regulations. No transactions, capital raising, or material business decisions are being announced through this filing.

Likely market impact

Neutral to mildly positive — routine investor outreach suggests continued engagement with the institutional community but a non-deal roadshow does not signal any immediate corporate action or fundraising.